4 results match your criteria: "MedStar Health Union Memorial Hospital[Affiliation]"
Pituitary
August 2024
LifeBridge Health Sinai Hospital, Baltimore, MD, 21215, USA.
J Community Hosp Intern Med Perspect
January 2022
Department of Medicine, MedStar Health Union Memorial Hospital, Baltimore, MD, USA.
Background: Sinus of Valsalva aneurysm (SOVA) is a rare anomaly of the aorta that can be congenital or acquired. It can be associated with syndromes such as Marfan syndrome and Ehlers-Danlos syndrome. However, to our knowledge, it has never been described in a patient with Apert syndrome.
View Article and Find Full Text PDFExpert Opin Biol Ther
March 2018
a Department of Neurology, Neuroimmunology Division/Neuroimaging Unit , Vanderbilt University Medical Center, Nashville , TN , USA.
Alemtuzumab is a monoclonal antibody that targets for the destruction CD52+ cells, particularly B and T cells. Alemtuzumab is approved in more than 50 countries around the world for the treatment of adult patients with relapsing remitting multiple sclerosis (MS). Areas covered: In this review, the authors summarize biological, clinical and safety data related to the use of alemtuzumab in patients with MS.
View Article and Find Full Text PDFTechnol Health Care
September 2018
Kinesiology Department, Towson University, Towson, MD, USA.
Background: Repeated mild traumatic brain injury (mTBI) has been associated with increased risk of degenerative neurological disorders. While the effects of mTBI and repeated injury are known, studies have only recently started examining repeated subconcussive impacts, impacts that do not result in a clinically diagnosed mTBI. In these studies, repeated subconcussive impacts have been connected to cognitive performance and brain imaging changes.
View Article and Find Full Text PDF